Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




SONALASENSE – $198,436

Amount
$198,436.00
Date
November 2022

A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG

Grant Information

UPMC Childrens Hospital of Pittsburgh – $100,000

Amount
$100,000.00
Date
November 2022

The Role of QPRT and NAD Pathways in DIPG Treatment Resistance (Continued)

Grant Information

The Hospital For Sick Children (SickKids) – $100,000

Amount
$100,000.00
Date
November 2022

Synthetic lethality screening with methionine restriction for treatment of DIPG

Grant Information

University of Texas MD Anderson Cancer Center – $100,000

Amount
$100,000.00
Date
November 2022

Viroimmunotherapy for pediatric brain tumors

Grant Information

Hunter Medical Research Institute – $200,000

Amount
$200,000.00
Date
November 2022

DMG COMBATT 2.0: Diffuse Midline Glioma COMbined Anti-Tumor Targeting 2.0

Grant Information

The Institute of Cancer Research – $501,183

Amount
$501,183.00
Date
November 2022

Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG)

Grant Information

Cincinnati Children's Hospital – $50,000

Amount
$50,000.00
Date
May 2022

Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma

Grant Information

SIOPe DIPG/DMG Registry – $779,018

Amount
$779,018.00
Date
March 2022

Renewal of the European DIPG/DMG Registry

Grant Information

Funding of PBTCF 2022 - $25,000

Amount
$25,000.00
Date
January 2022

Massachusetts General Hospital – $50,000

Amount
$50,000.00
Date
November 2021

Targeted Protein Degradation for DIPG Therapy

Grant Information

CONNECT2007 - $345,794

Amount
$345,794.00
Date
September 2021

Phase I/II Study of Lutathera in Pediatric and Young Adult Patients with Recurrent and/or Progressive High-Grade Central Nervous System (CNS) Tumors and Meningiomas which Express Somatostatin Type 2A Receptors and Demonstrate Uptake on DOTATATE

Grant Information

CONNECT2109A - $705,764

Amount
$705,764.00
Date
September 2021

CONNECT2109A: A molecularly-guided phase II study of ribociclib and everolimus in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG)

Grant Information

CONNECT Consortium - $278,619

Amount
$278,619.00
Date
September 2021

Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors

Grant Information

Institute of Cancer Research – $113,747

Amount
$113,747.00
Date
September 2021

Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG

Grant Information

Institute of Cancer Research – $498,716

Amount
$498,716.00
Date
September 2021

Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical

Grant Information